We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+15.15%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$378M
AUM Growth
-$30.8M
(-7.5%)
Cap. Flow
-$48.2M
Cap. Flow
% of AUM
-12.74%
Top 10 Holdings %
Top 10 Hldgs %
10.62%
Holding
337
New
95
Increased
51
Reduced
79
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CUTR
Cutera, Inc.
CUTR
|
+$4M |
| 2 |
Addus HomeCare
ADUS
|
+$3.26M |
| 3 |
PennyMac Financial
PFSI
|
+$2.77M |
| 4 |
EverQuote
EVER
|
+$2.71M |
| 5 |
Independence Realty Trust
IRT
|
+$2.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Napco Security Technologies
NSSC
|
+$4.11M |
| 2 |
NeoGenomics
NEO
|
+$3.62M |
| 3 |
NMI Holdings
NMIH
|
+$3.44M |
| 4 |
EVRI
Everi Holdings
EVRI
|
+$3.34M |
| 5 |
Freshpet
FRPT
|
+$3.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.79% |
| 2 | Healthcare | 23.79% |
| 3 | Industrials | 13.71% |
| 4 | Consumer Discretionary | 12.39% |
| 5 | Financials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ODT
201
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $822K | 0.22% |
+31,564
| New | +$1.06M |
|
|
ACHN
202
DELISTED
Achillion Pharmaceuticals
ACHN
| $796K | 0.21% |
+221,011
| New | +$852K |
|
203
Kura Sushi USA
KRUS
$575M
| $770K | 0.2% |
+39,268
| New | +$864K |
|
|
RETA
204
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $735K | 0.19% |
9,150
-19,783
| -68% | -$1.68M |
|
|
ENZ
205
DELISTED
Enzo Biochem, Inc.
ENZ
| $734K | 0.19% |
203,962
+25,023
| +14% | +$88.6K |
|
206
Viemed Healthcare
VMD
$452M
| $731K | 0.19% |
+105,951
| New | +$706K |
|
|
RADA
207
DELISTED
Rada Electronic Industries Ltd
RADA
| $674K | 0.18% |
+141,640
| New | +$596K |
|
|
SILV
208
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $672K | 0.18% |
128,675
-63,634
| -33% | -$340K |
|
|
ATXI
209
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $669K | 0.18% |
100
+33
| +49% | +$225K |
|
210
LGL Group
LGL
$45.1M
| $668K | 0.18% |
+172,245
| New | +$591K |
|
211
Ovid Therapeutics
OVID
$435M
| $668K | 0.18% |
+206,118
| New | +$468K |
|
|
SAFE
212
DELISTED
Safehold Inc.
SAFE
| $662K | 0.18% |
21,717
-24,419
| -53% | -$744K |
|
213
XBiotech
XBIT
$68.3M
| $660K | 0.17% |
63,108
+1,781
| +3% | +$14.5K |
|
214
Inseego
INSG
$118M
| $658K | 0.17% |
13,716
-20,409
| -60% | -$949K |
|
215
Arcturus Therapeutics
ARCT
$169M
| $654K | 0.17% |
+63,640
| New | +$688K |
|
|
CTHR
216
DELISTED
Charles & Colvard Ltd
CTHR
| $654K | 0.17% |
40,102
+992
| +3% | +$14.4K |
|
|
ZIXI
217
DELISTED
Zix Corporation
ZIXI
| $647K | 0.17% |
89,332
-324,175
| -78% | -$2.7M |
|
218
Castle Biosciences
CSTL
$899M
| $615K | 0.16% |
+34,005
| New | +$754K |
|
219
Quanterix
QTRX
$167M
| $615K | 0.16% |
28,002
-12,525
| -31% | -$349K |
|
220
Victory Capital Holdings
VCTR
$6.4B
| $615K | 0.16% |
40,010
-43,598
| -52% | -$746K |
|
221
Intellicheck
IDN
$74.7M
| $609K | 0.16% |
122,080
+3,481
| +3% | +$17.4K |
|
|
222
Napco Security Technologies
NSSC
$1.35B
| $609K | 0.16% |
47,700
-291,756
| -86% | -$4.11M |
|
223
Fate Therapeutics
FATE
$294M
| $599K | 0.16% |
38,540
-32,259
| -46% | -$618K |
|
|
MSON
224
DELISTED
Misonix Inc
MSON
| $593K | 0.16% |
29,500
-54,880
| -65% | -$1.19M |
|
|
CDMO
225
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $589K | 0.16% |
+111,208
| New | +$690K |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q3 2019 Portfolio in Review
As of Q3 2019, EAM Investors held 337 positions worth $378M, down 7.5% from $409M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
EAM Investors withdrew a net $48.2M in Q3 2019, closing 108 positions and reducing 79 holdings. Its most notable exit was NeoGenomics, an estimated $3.62M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, EAM Investors opened a new position in Cutera, Inc. worth $4.26M.
- EAM Investors's largest Q3 2019 buy was Cutera, Inc.: 145,624 shares worth $4.26M.
- EAM Investors added most to MobileIron, Inc. in Q3 2019, an estimated $2.02M increase.
- EAM Investors's biggest Q3 2019 reduction was Napco Security Technologies, cutting an estimated $4.11M.
- EAM Investors fully exited NeoGenomics in Q3 2019, selling an estimated $3.62M.
- EAM Investors's ten largest holdings make up 11% of its $378M portfolio in Q3 2019.
- EAM Investors opened 95 new positions and closed 108 in Q3 2019.
- EAM Investors's portfolio value fell 7.5% quarter-over-quarter to $378M.
Based on EAM Investors's 13F filing for Q3 2019, filed 13 Nov 2019.